Can a simple blood test spot cancer early? 25,000 volunteers help find out

NCT ID NCT06589310

Recruiting now Diagnosis Sponsor: Exact Sciences Corporation Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This registry study is testing a blood test designed to detect multiple types of cancer early by looking for DNA and protein changes linked to cancer. Researchers will follow 25,000 people aged 50 to 80 who take the test and any follow-up imaging. The goal is to see how well the test works in real-world settings and whether it helps catch cancer sooner.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Exact Sciences Multicancer Early Detection (MCED) blood test
What this could lead to: If successful, this could show that a simple blood test can catch several types of cancer early, potentially improving survival rates.
What could go wrong: This is an observational registry, not a controlled trial. The test may produce false positives or miss some cancers, and results may not apply to everyone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cancer neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CANCER

Contacts and locations

Locations

Baylor Scott & White Health
RECRUITING

Dallas, Texas, 75246, United States
Endeavor Health
RECRUITING

Evanston, Illinois, 60201, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.